Alveolar macrophages in HIV-1 infection express accessory molecules, activation markers, and release increased biological response modifiers.
Agostini
C
C
Padua University School of Medicine, Department of Clinical Medicine, Italy.
Trentin
L
L
Zambello
R
R
Bulian
P
P
Garbisa
S
S
Cipriani
A
A
Cadrobbi
P
P
Semenzato
G
G
D000386:AIDS-Related Complex / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000328:Adult; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D005260:Female; D005786:Gene Expression Regulation / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000032:analysis; D015658:HIV Infections / Q000276:immunology*; D006679:HIV Seropositivity / Q000276:immunology; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology*; D015850:Interleukin-6 / Q000032:analysis; D008262:Macrophage Activation / Q000276:immunology*; D016676:Macrophages, Alveolar / Q000276:immunology*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D007155:Immunologic Factors; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D016178:Granulocyte-Macrophage Colony-Stimulating Factor